Cargando…
The contribution of the intestinal microbiome to immune recovery after HCT
Allogenic hematopoietic stem-cell transplantation (allo-HCT) is a curative-intent immunotherapy for high-risk hematological malignancies and immune deficiencies. Allo-HCT carries a high risk of treatment-related mortality (TRM), largely due to infection or graft-versus-host disease (GVHD). Robust im...
Autores principales: | Wolfe, Alex E., Markey, Kate A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434312/ https://www.ncbi.nlm.nih.gov/pubmed/36059482 http://dx.doi.org/10.3389/fimmu.2022.988121 |
Ejemplares similares
-
The sweet taste of liberalizing dietary restrictions in HCT
por: Peled, Jonathan U., et al.
Publicado: (2023) -
Biomarkers for Allogeneic HCT Outcomes
por: Adom, Djamilatou, et al.
Publicado: (2020) -
Gamma delta T-cell reconstitution after allogeneic HCT: A platform for cell therapy
por: Gaballa, Ahmed, et al.
Publicado: (2022) -
Intraepithelial lymphocytes in the pig intestine: T cell and innate lymphoid cell contributions to intestinal barrier immunity
por: Wiarda, Jayne E., et al.
Publicado: (2022) -
The role of the intestinal microbiome in antiphospholipid syndrome
por: van Mourik, Dagmar J. M., et al.
Publicado: (2022)